Paul Tudor Jones Warns No Chance Fed Will Cut Rates Under Warsh Groupon GRPN Q1 2026 Results Fall Short EPS 031 Revenue NA What Youlife YOULs 207 Decline Means for Investors 20260518 Swatch CEO Embraces Chaos as Exclusive Pocket Watch Launch Triggers Surge in UK Store Demand Toms Group CEO Annette Zeipel Navigates GLP1 Trends and Cocoa Volatility While Maintaining Sales Growth Target Australian Developer Scraps Trump Hotel Project Cites Toxic Brand Image Indias Mega Offshore Oil and Gas Exploration Mission Sector Implications and Key Companies Under Market Watch Mattel MAT Q1 2026 Earnings 020 EPS Surges Past 021 Estimates Berkshire Hathaway Boosts Airline and Tech Holdings Delta Stake and Alphabet Increase Rail Vikas Nigam Reports Mixed Q4 Results Profit Slumps 59 Revenue Up 42 Declares Final Dividend Soybeans Maintain Positive Momentum Heading into Extended Holiday Break Nvidias Earnings Reveal 200 Billion Edge Computing Opportunity Amid China Market Challenges USChina Trade Soybean and Rare Earths Deals Emerge After TrumpXi Summit Morocco Seeks Western Tourists for Western Sahara Raising Sovereignty Concerns CELH Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction CTNM Q1 2026 Earnings Narrower Loss Beats Estimates as PreRevenue Biotech Maintains Discipline MCHP Q1 2026 Earnings EPS Beats Consensus by 106 Stock Rises Nearly 3 Newton Golf Company Inc NWTG Q1 2026 Earnings Wider Loss as PreRevenue Company Misses Estimates SY Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Sentiment as Revenue Remains Under Wraps REZI Q1 2026 Earnings Solid Earnings Beat Amid Market Caution TTAN Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Recurring Revenue Growth GE Q1 2026 Earnings EPS Beat Drives Slight Stock Uptick Amid Operational Focus MDWD Q4 2025 Earnings Narrower Loss Beats Estimates as Operational Focus Continues BlackRock BLK Q1 2026 Earnings EPS Surges Past Estimates Stock Gains on Strong Core Business Baker Hughes Q1 2026 Earnings EPS Surges 16 Above Expectations Oil Prices Edge Higher as Market Skepticism Grows Over USIran Diplomatic Progress Tango Therapeutics Q1 2026 Earnings Slight EPS Miss as PreRevenue Biotech Focuses on Pipeline Progress